Showing 5791-5800 of 9242 results for "".
Strength in Numbers: Assessing Your Financial Position
https://practicaldermatology.com/topics/practice-management/strength-in-numbers-assessing-your-financial-position/23863/Look at your ratios and ranges to make sure you are keeping up with industry—and economic—shifts.Comorbidities in Vitiligo
https://practicaldermatology.com/issues/august-2025/comorbidities-in-vitiligo/36702/Vitiligo is a chronic, acquired pigmentary disorder characterized by the progressive loss of function or destruction of melanocytes in the skin, hair follicles, and mucous membranes. In this piece, Dr. Brad Glick and colleagues explore comorbidities in vitiligo.Finding and Taking Advantage of Your Employees' Strengths
https://practicaldermatology.com/topics/practice-management/finding-and-taking-advantage-of-your-employees-strengths/20435/Tips for successfully incorporating a strength-based approach to staff management.Intralesional Cryosurgery: A Novel Treatment for Keloid Scars
https://practicaldermatology.com/topics/general-topics/intralesional-cryosurgery-a-novel-treatment-for-keloid-scars/22933/Intralesional cryosurgery appears to allow for focused destruction of keloid scar tissue with minimal damage to the surface of the skin.Optimizing Absorption of Oral Isotretinoin
https://practicaldermatology.com/columns/clinical-focus-1/optimizing-absorption-of-oral-isotretinoin/23066/An update on lidose-isotretinoin and the ability to enhance absorption in the absence of high-fat meals.Basal Cell Carcinoma in Skin of Color: A Case Series
https://practicaldermatology.com/topics/skin-cancer-photoprotection/basal-cell-carcinoma-in-skin-of-color-a-case-series/23814/BCC is not common in patients with skin of color; it tends to have a delayed diagnosis and can have a more serious disease course.Comorbidities in Atopic Dermatitis
https://practicaldermatology.com/issues/october-2025/comorbidities-in-atopic-dermatitis/39756/In this article, as part of a series on comorbidities associated with immune-mediated skin diseases, we explore the spectrum of comorbidities linked to AD.The Case for JAK Inhibitors to Treat AD
https://practicaldermatology.com/topics/atopic-dermatitis/case-jak-inhibitors-treat-ad/27109/E. James Song, MD, FAAD, Director of Clinical Research and Co-Chief Medical Officer for Frontier Dermatology, discusses his presentation “JAK Inhibitors in Atopic Dermatitis” from the 2024 American Academy of Dermatology (AAD) Innovation Academy.Increase Tax Deductions and Boost Retirement Savings with a Cash Balance Plan
https://practicaldermatology.com/topics/practice-management/increase-tax-deductions-andboost-retirement-savings-with-a-cash-balance-plan/23076/A smart strategy you may not be considering.The Language of Appreciation
https://practicaldermatology.com/topics/practice-management/the-language-of-appreciation/60987/Communication is about far more than personnel retention.